Lexicon Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Good morning, everyone. Welcome to another session here at the second day of Oppenheimer's Virtual Fall Healthcare Summit. We are delighted to have with us Lexicon Pharmaceuticals. On behalf of Lexicon, we'll have the Company's CEO, Lonnel Coats, who will be walking through a presentation on the Company, and we will also have some time for questions at the end. If you have any questions you would like to submit, please do through -- do so through the Zoom chat function and I'll do my best to ask on your behalf.
And with that, I'll turn the microphone over to Lonnel.
Leland, thank you for your warm introduction and having us at this conference today. Let me start off by saying that Lexicon is making great progress and we look forward to sharing that progress with you today. But before I get started, I want to say that we will be making forward-looking statements today that are subject to risks and uncertainties. Certainly those risks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |